Details of the Drug

General Information of Drug (ID: DML77QD)

• Drug Name: IMC-2013

Indication

Disease Entry	ICD 11	Status	REF
Osteoarthritis	FA00-FA05	Phase 1	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: DBIQ02

References

• [1] Clinical pipeline report, company report or official report of ImmuneCyte